Literature DB >> 17628448

Heart development in fibronectin-null mice is governed by a genetic modifier on chromosome four.

Sophie Astrof1, Andrew Kirby, Kerstin Lindblad-Toh, Mark Daly, Richard O Hynes.   

Abstract

Absence of the fibronectin (FN) gene leads to early embryonic lethality in both 129S4 and C57BL/6J strains due to severe cardiovascular defects. However, heart development is arrested at different stages in these embryos depending on the genetic background. In the majority of 129S4 FN-null embryos, heart progenitors remain at their anterior bilateral positions and fail to fuse at the midline to form a heart tube. However, on the C57BL/6J genetic background, cardiac development progresses further and results in a centrally positioned and looped heart. To find factor(s) involved in embryonic heart formation and governing the extent of heart development in FN-null embryos in 129S4 and C57BL/6J strains, we performed genetic mapping and haplotype analyses. These analyses lead to identification of a significant linkage to a 1-Mbp interval on chromosome four. Microarray analysis and sequencing identified 21 genes in this region, including five that are differentially expressed between the strains, as potential modifiers. Since none of these genes was previously known to play a role in heart development, one or more of them is likely to be a novel modifier affecting cardiac development. Identification of the modifier would significantly enhance our understanding of the molecular underpinning of heart development and disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628448     DOI: 10.1016/j.mod.2007.05.004

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  14 in total

1.  Endothelial alpha5 and alphav integrins cooperate in remodeling of the vasculature during development.

Authors:  Arjan van der Flier; Kwabena Badu-Nkansah; Charles A Whittaker; Denise Crowley; Roderick T Bronson; Adam Lacy-Hulbert; Richard O Hynes
Journal:  Development       Date:  2010-07       Impact factor: 6.868

2.  A novel method, the Variant Impact On Linkage Effect Test (VIOLET), leads to improved identification of causal variants in linkage regions.

Authors:  Lisa J Martin; Lili Ding; Xue Zhang; Ahmed H Kissebah; Michael Olivier; D Woodrow Benson
Journal:  Eur J Hum Genet       Date:  2013-06-05       Impact factor: 4.246

3.  Strain-specific modifier genes governing craniofacial phenotypes.

Authors:  Partha Mukhopadhyay; Guy Brock; Cynthia Webb; M Michele Pisano; Robert M Greene
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-02-28

Review 4.  Extracellular matrix and heart development.

Authors:  Marie Lockhart; Elaine Wirrig; Aimee Phelps; Andy Wessels
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-25

5.  Fibronectin and integrin alpha 5 play requisite roles in cardiac morphogenesis.

Authors:  Ashok Mittal; Maria Pulina; Shuan-Yu Hou; Sophie Astrof
Journal:  Dev Biol       Date:  2013-06-17       Impact factor: 3.582

6.  Essential roles of fibronectin in the development of the left-right embryonic body plan.

Authors:  Maria V Pulina; Shuan-Yu Hou; Ashok Mittal; Dorthe Julich; Charlie A Whittaker; Scott A Holley; Richard O Hynes; Sophie Astrof
Journal:  Dev Biol       Date:  2011-04-03       Impact factor: 3.582

7.  Role for p21-activated kinase PAK4 in development of the mammalian heart.

Authors:  Tanya Nekrasova; Audrey Minden
Journal:  Transgenic Res       Date:  2011-12-16       Impact factor: 2.788

Review 8.  New insights into form and function of fibronectin splice variants.

Authors:  E S White; F E Baralle; A F Muro
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

Review 9.  Fibronectins in vascular morphogenesis.

Authors:  Sophie Astrof; Richard O Hynes
Journal:  Angiogenesis       Date:  2009-02-14       Impact factor: 9.596

Review 10.  Extracellular matrix-based biomaterials for cardiac regeneration and repair.

Authors:  Haotong Li; Minghui Bao; Yu Nie
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.